振东制药 (300158.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(振东制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 44.0049.0055.0051.0047.0046.0051.0053.0048.00
 单季度销售净利率(%) 3.00-5.00-2.001.00--8.00-2.001.00
 单季度净资产收益率ROE(%) --1.00----1.00---
 单季度总资产净利率ROA(%) --1.00----1.00---
单季度财务摘要:
 单季度营业总收入(元) 782,130,269.00842,270,688.00850,856,603.00981,471,683.00951,417,159.00929,393,497.001,073,527,851.00836,797,258.00888,836,734.00
 单季度营业总成本(元) 795,147,633.00981,921,386.00874,170,989.00943,553,053.00977,786,838.001,063,835,037.001,099,992,381.00857,327,015.00901,037,498.00
 单季度营业收入(元) 782,130,269.00842,270,688.00850,856,603.00981,471,683.00951,417,159.00929,393,497.001,073,527,851.00836,797,258.00888,836,734.00
 单季度营业利润(元) 32,289,666.00-41,720,793.00-16,844,800.0021,277,920.007,304,229.00-74,756,503.0010,905,642.0039,863,906.0018,066,567.00
 单季度利润总额(元) 30,993,193.00-48,850,047.00-18,332,653.0022,047,931.007,442,111.00-72,467,573.0011,420,914.0037,714,939.0018,051,242.00
 单季度净利润(元) 22,347,124.00-43,735,129.00-16,343,394.0013,111,386.00-902,066.00-77,891,470.00-2,031,237.0015,109,172.007,814,691.00
 单季度归属母公司股东的净利润(元) 23,101,558.00-43,109,911.00-15,416,615.0014,937,139.00-394,729.00-76,034,514.0099,113.0015,495,502.009,149,859.00
 单季度经营活动产生的现金流量(元) -23,874,405.00-25,907,512.00-115,471,782.00113,716,898.00-221,509,803.00181,627,276.00-74,648,567.00-92,010,133.0071,339,619.00
 单季度投资活动产生的现金流量(元) -43,843,438.00-160,675,778.00205,404,279.0069,448,057.00358,662,040.00-354,326,076.00188,953,642.003,070,809,059.00-513,387,115.00
 单季度筹资活动产生的现金流量(元) -83,853,620.0011,241,711.00885,374.00-45,725,400.00-110,972,152.00-305,063,777.00-258,233,752.00-2,393,354,127.00-22,104,128.00
 单季度现金及现金等价物净增加(元) -151,571,463.00-175,341,579.0090,817,870.00137,439,555.0026,180,084.00-477,762,577.00-143,928,676.00585,444,799.00-464,151,625.00

前瞻产业研究院